Company Filing History:
1 out of 49 
1 out of 60 
1 out of 5 Years Active: 2015
Title: Aritaka Nagadoi: Innovator in Neurobiology and Therapeutic Solutions
Introduction
Aritaka Nagadoi is a prominent inventor based in Yokohama, Japan, known for his groundbreaking contributions to neurobiology. With a focus on therapeutic advancements, he has developed innovations that hold potential for treating significant neurological conditions.
Latest Patents
Aritaka Nagadoi holds a patent for the "Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)." This invention identifies a compound capable of binding to the PAH1 domain of mSin3B, which is critical for addressing abnormalities in neural restrictive silencer factor NRSF/REST. The implications of this patent include potential treatments for diseases such as Huntington's disease, medulloblastoma, and neuropathic pain. The patent details a pharmaceutical composition containing compounds that can effectively target the specified pathways, thereby contributing to the medical field.
Career Highlights
Throughout his career, Aritaka has made notable strides in the academic and research sectors. His affiliations include the Public University Corporation Yokohama City University and Nagasaki University, where he has contributed to various research initiatives, enhancing the understanding of neurological disorders and their treatments.
Collaborations
Aritaka Nagadoi has collaborated with esteemed colleagues, including Yoshifumi Nishimura and Yuuka Hirao. Their teamwork has fostered an innovative environment that leads to the discovery of new therapeutic methods and enhances the overall impact of their research on the scientific community.
Conclusion
Aritaka Nagadoi's work exemplifies the vital intersection of invention and health. With his patent addressing crucial aspects of neurological diseases, he stands as a testament to the role inventors play in transforming science and medicine. Through his collaborations and ongoing research, Nagadoi continues to pave the way for future innovations in the field of neurobiology.